237 related articles for article (PubMed ID: 27872975)
41. Solitary colorectal liver metastasis after curative intent surgery: prognostic factors affecting outcomes and survival.
Shin H; Kim CW; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
ANZ J Surg; 2019 Jan; 89(1-2):61-67. PubMed ID: 30484933
[TBL] [Abstract][Full Text] [Related]
42. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
[TBL] [Abstract][Full Text] [Related]
43. [The significance of the preoperative CEA value for the prognosis of rectal cancer].
Mentges B; Brückner R; Weiss C
Langenbecks Arch Chir; 1990; 375(2):106-11. PubMed ID: 2329893
[TBL] [Abstract][Full Text] [Related]
44. Elevated tumor-to-liver uptake ratio (TLR) from
Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
[TBL] [Abstract][Full Text] [Related]
45. Prognostic factors of local recurrence and survival after curative rectal cancer surgery: a single institution experience.
Boras Z; Kondza G; Sisljagić V; Busić Z; Gmajnić R; Istvanić T
Coll Antropol; 2012 Dec; 36(4):1355-61. PubMed ID: 23390833
[TBL] [Abstract][Full Text] [Related]
46. The robust performance of carcinoembryonic antigen levels after adjuvant chemotherapy for the recurrence risk stratification in patients with colorectal cancer.
Ozawa T; Matsuda K; Ishihara S; Fukushima Y; Shimada R; Hayama T; Nozawa K; Hashiguchi Y
J Surg Oncol; 2021 Jul; 124(1):97-105. PubMed ID: 33848373
[TBL] [Abstract][Full Text] [Related]
47. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
[TBL] [Abstract][Full Text] [Related]
48. The role of preoperative CEA in the management of colorectal cancer: A cohort study from two cancer centres.
Baqar AR; Wilkins S; Staples M; Angus Lee CH; Oliva K; McMurrick P
Int J Surg; 2019 Apr; 64():10-15. PubMed ID: 30822523
[TBL] [Abstract][Full Text] [Related]
49. Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer.
Mallappa S; Sinha A; Gupta S; Chadwick SJ
Colorectal Dis; 2013 Mar; 15(3):323-8. PubMed ID: 22958479
[TBL] [Abstract][Full Text] [Related]
50. Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
Kim CW; Yu CS; Yang SS; Kim KH; Yoon YS; Yoon SN; Lim SB; Kim JC
Ann Surg Oncol; 2011 Nov; 18(12):3271-7. PubMed ID: 21537868
[TBL] [Abstract][Full Text] [Related]
51. A high preoperative carbohydrate antigen 19-9 level is a risk factor for recurrence in stage II colorectal cancer.
Nozawa H; Ishihara S; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Sasaki K; Murono K; Watanabe T
Acta Oncol; 2017 May; 56(5):634-638. PubMed ID: 27885879
[TBL] [Abstract][Full Text] [Related]
52. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
53. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer.
Lee MR; Hong CW; Yoon SN; Lim SB; Park KJ; Lee MJ; Kim WH; Park JG
J Surg Oncol; 2006 Jan; 93(1):13-8; discussion 18-9. PubMed ID: 16353185
[TBL] [Abstract][Full Text] [Related]
54. Prognostic Significance of Preoperative Serum Carbohydrate Antigen 19-9 in Patients With Stage IV Colorectal Cancer.
Ozawa T; Ishihara S; Kawai K; Nozawa H; Yamaguchi H; Kitayama J; Watanabe T
Clin Colorectal Cancer; 2016 Dec; 15(4):e157-e163. PubMed ID: 27245559
[TBL] [Abstract][Full Text] [Related]
55. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
[TBL] [Abstract][Full Text] [Related]
56. Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer.
Lin JK; Lin CC; Yang SH; Wang HS; Jiang JK; Lan YT; Lin TC; Li AF; Chen WS; Chang SC
Int J Colorectal Dis; 2011 Sep; 26(9):1135-41. PubMed ID: 21538056
[TBL] [Abstract][Full Text] [Related]
57. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
[TBL] [Abstract][Full Text] [Related]
58. Preoperative carcinoembryonic antigen elevation in colorectal cancer.
Yeh CY; Hsieh PS; Chiang JM; Lai CC; Chen JS; Wang JY; Hung HY
Hepatogastroenterology; 2011; 58(109):1171-6. PubMed ID: 21937372
[TBL] [Abstract][Full Text] [Related]
59. Clinically Applicable Serum Biomarkers Among 14 Candidates Associated With Recurrence of Stage II and III Colorectal Cancer.
Kim CW; Ha YJ; Tak KH; Roh SA; Kim SK; Kim SY; Kim YS; Cho DH; Kim JC
Anticancer Res; 2021 Sep; 41(9):4651-4658. PubMed ID: 34475094
[TBL] [Abstract][Full Text] [Related]
60. Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision.
Lee JH; Jang HS; Kim JG; Cho HM; Shim BY; Oh ST; Yoon SC; Kim YS; Choi BO; Kim SH
Ann Surg Oncol; 2012 Apr; 19(4):1213-21. PubMed ID: 21935746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]